Edwards Training Village at EACTS 2025
Edwards Training Village: Hands-on experience with EVOQUE TTVR and SAPIEN M3 TMVR system
Join us for an immersive workshop on the latest transcatheter replacement therapies for mitral and tricuspid regurgitation. This interactive session will introduce you to the EVOQUE and SAPIEN M3 systems and will give you the opportunity to take part in a hands-on experience simulating a complete procedure.
Thursday 9 Oct 2025
Hands-On Experience with EVOQUE TTVR and 12:00 SAPIEN M3 TMVR system
Hands-On Experience with EVOQUE TTVR and 12:00 SAPIEN M3 TMVR system
Hands-On Experience with EVOQUE TTVR and 12:00 SAPIEN M3 TMVR system
Friday 10 Oct 2025
Hands-On Experience with EVOQUE TTVR and 12:00 SAPIEN M3 TMVR system
Hands-On Experience with EVOQUE TTVR and 12:00 SAPIEN M3 TMVR system
Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up of up to 10 years in process.
Reference: Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024 Sep;168(3):781-791.
Expert opinions, advice and all other information represent contributor’s views and not necessarily those of Edwards Lifesciences.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).